MENU

APLS Stock Apellis Pharmaceuticals (APLS, $38.88) was a top loser this quarter, falling -22.02%

A.I.dvisor
at Tickeron.com
07/26/24
Loading...
APLS - Apellis Pharmaceuticals

Loading...

Price: $38.88
Daily change: +$1.49 (+3.99%)
Daily volume: 1.7M
3-month price change: -$10.98 (-22.02%)
Capitalization: $4.7B
Industry: Biotechnology
Apellis Pharmaceuticals (APLS, $38.88) was a top loser over the last three months, falling -2 to $38.88 per share. A.I.dvisor analyzed 873 stocks in the Biotechnology Industry for the 3-month period ending July 25, 2024, and found that of them (6) exhibited an Uptrend while of them (3) demonstrated a Downtrend.
View a ticker or compare two or three
APLS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of therapeutics and drug delivery technologies to address chronic inflammatory diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Medical Distributors
Address
100 Fifth Avenue
Phone
+1 617 977-5700
Employees
706
Web
https://www.apellis.com